NRXP: NRx Pharmaceuticals, Inc. Stock

by  •  • Comments Off on NRXP: NRx Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 34.13
Enterprise Value ($M) 38.52
Book Value ($M) -18.82
Book Value / Share -1.56
Price / Book -1.81
NCAV ($M) -19.18
NCAV / Share -1.59
Price / NCAV -1.78

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -2.79
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.20
Current Ratio 0.20

Balance Sheet (mrq) ($M)
Current Assets 4.11
Assets 4.46
Liabilities 23.28
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)
Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-29 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended: December 31, 2023 ☐ TRANSITION REPORT PURSU

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-04 155,078 452,794 34.25
2025-02-03 94,370 377,184 25.02
2025-01-31 109,429 417,106 26.24
2025-01-30 162,881 436,749 37.29

(click for more detail)

Similar Companies
NKTR – Nektar Therapeutics NLSP – NLS Pharmaceutics AG
NRSN – NeuroSense Therapeutics Ltd. NVCT – Nuvectis Pharma, Inc.
OCEA – Ocean Biomedical, Inc.


Financial data and stock pages provided by
Fintel.io